AMFB was became generally known by Fletcher et al. [
8] in 1992, who described ten cases involving the vulva AMFB occurs primarily in the vulvo-vaginal area (predominantly the vulva) of middle-aged women. Rare cases have also been reported to arise in the scrotum and the inguinal area in males [
8,
9]. Between 1999 and 2013, there were only 57 publications in english literature of AMFB. With biologic behavior, all published reports suggest a benign clinical outcome in patients with AMFB. To our knowledge, only one reported case underwent a sarcomatous transformation [
10] and no recurrence. The occurring average age of female is 45.8 years and rather slow growing (from few weeks to 13 years) without pain [
5]. Clinically, these tumors are misdiagnosed as Bartholin gland cyst, inguinal hernia, leiomyoma, or mesenchymal tumors, such as lipoma and liposarcoma [
11]. On gross examination of the tumor, they are typically well circumscribed and hard with rubbery consistency, with size that ranged from 0.5 to 12 cm. Most of the tumors are pink in color [
5]. Microscopic examination shows well-demarcated lesion and alternating hypercellular and hypocellular edematous legions with abundant blood vessels. Nuclear atypicality or mitotic figures are rare and the tumor cells tend to cluster around blood vessels [
5]. Sometimes adipocytes are scattered within the mass, and these tumors have been classified as the "lipomatous" variant of AMFB. AMFB can be distinguished from the aggressive angiomyxoma by its circumscribed borders; AMFB has chubby stromal cells and the stromal cell condenses the perivascular area [
12]. Immunohistochemical findings show that the tumors are staining for vimentin and desmin in most cases. The tumor cells also show variable expression for muscle actin and are positive for estrogen and/or progesterone receptors [
5]. Because of this hormonal receptor expression, the tumor suggests that it might arise from hormonally responsible mesenchymal cells [
3]. The patient underwent simple excision with clear margin of the lesion. Despite our recommendation for regular follow up, the patient did not comply for seven years and we finally decided to follow up with her by a telephone call. She said she almost forgot about the mass removal event and there is no evidence of recurrence. This paper aims to announce AMFB of vulvar as an rare tumor. The treatment of choice is a surgical excision with clear margins.